share_log

Wells Fargo Downgrades Axonics to Equal-Weight, Raises Price Target to $71

Wells Fargo Downgrades Axonics to Equal-Weight, Raises Price Target to $71

富國銀行將Axonics的評級下調至同等權重,將目標股價上調至71美元
Benzinga ·  01/10 06:50

Wells Fargo analyst Larry Biegelsen downgrades Axonics (NASDAQ:AXNX) from Overweight to Equal-Weight and raises the price target from $68 to $71.

富國銀行分析師拉里·比格爾森將Axonics(納斯達克股票代碼:AXNX)的評級從增持下調至同等,並將目標股價從68美元上調至71美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論